Closing The Gap? Pfizer Will Set Same US, Foreign Launch Prices In MFN Deal

Pfizer said it acceded to Trump Administration demands for US and foreign drug pricing parity. (Screenshot of White House Broadcast)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Pricing Debate

More from Market Access